Zoetis Inc

ZTS

NYSE

Pharmaceuticals

$75.02

USD

-1.66 (-2.16%)

At close: Aug 20, 2026, 4:00 PM EDT

Market Cap $30.19B

Volume 3.9M

Overview Charts Financials Peers Filings & News Analyst Ratings Technical Analysis

Latest News

No news yet

SEC Filings & Disclosures

10-K

Quantli Newsdesk

· 4 months ago

Zoetis 2025: 2% Revenue Growth to $9.5B, Net Income Rises 8% to $2.7B Despite Livestock Headwinds

Zoetis generated $9.5 billion in revenue in 2025, up 2%, while net income rose 8% to $2.7 billion. Companion animal strength offset livestock declines and divestiture impacts.

ZTS

Market Analysis

No market analysis yet

Similar Stocks

BMY

Bristol-Myers Squibb Co

$65.47

▼ -3.2%

JNJ

Johnson & Johnson

$267.37

▼ -2.2%

ELAN

Elanco Animal Health Inc

$23.56

▼ -3.8%

PFE

Pfizer Inc

$27.79

▼ -1.6%

MRK

Merck & Co Inc

$148.99

▼ -2.1%

LLY

Eli Lilly and Co

$1244.40

▼ -2.8%